Trial
NCT00731874
Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Weill Medical College of Cornell University
Collaborators
—
Condition
Immunosuppression
Intervention
Tacrolimus
Why stopped
A higher rate of late rejection was seen in the low tacrolimus arm.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-12